Terms: = Breast cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Diagnosis
48 results:
1. Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort.
de Ligt KM; de Rooij BH; Walraven I; Heins MJ; Verloop J; Siesling S; Korevaar JC; van de Poll-Franse LV
Support Care Cancer; 2022 Oct; 30(10):7873-7883. PubMed ID: 35727375
[TBL] [Abstract] [Full Text] [Related]
2. Early Diagnostic Markers and Therapeutic Targets for Experimental breast cancer.
Ermakova NN; Pershina OV; Zhukova MA; Pakhomova AV; Pan ES; Sandrikina LA; Krupin VA; Rybalkina OY; Dygai AM; Skurikhin EG
Bull Exp Biol Med; 2022 Apr; 172(6):747-751. PubMed ID: 35501655
[TBL] [Abstract] [Full Text] [Related]
3. Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis.
Malgaroli M; Szuhany KL; Riley G; Miron CD; Park JH; Rosenthal J; Chachoua A; Meyers M; Simon NM
J Cancer Surviv; 2023 Oct; 17(5):1510-1521. PubMed ID: 35224684
[TBL] [Abstract] [Full Text] [Related]
4. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of ER, PR and HER2 markers by flow cytometry for breast cancer diagnosis and prognosis.
Wopereis S; Walter LO; Vieira DSC; Ribeiro AAB; Fernandes BL; Wilkens RS; Santos-Silva MC
Clin Chim Acta; 2021 Dec; 523():504-512. PubMed ID: 34762935
[TBL] [Abstract] [Full Text] [Related]
6. Neighborhood archetypes and breast cancer survival in California.
Shariff-Marco S; DeRouen MC; Yang J; Jain J; Nelson DO; Weden MM; Gomez SL
Ann Epidemiol; 2021 May; 57():22-29. PubMed ID: 33577928
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic challenges and potential early indicators of breast periprosthetic anaplastic large cell lymphoma: A case report.
La Forgia D; Catino A; Fausto A; Cutrignelli D; Fanizzi A; Gatta G; Losurdo L; Maiorella A; Moschetta M; Ressa C; Scattone A; Portincasa A
Medicine (Baltimore); 2020 Jul; 99(30):e21095. PubMed ID: 32791685
[TBL] [Abstract] [Full Text] [Related]
8. SERS studies on normal epithelial and cancer cells derived from clinical breast cancer specimens.
Shen L; Du Y; Wei N; Li Q; Li S; Sun T; Xu S; Wang H; Man X; Han B
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Aug; 237():118364. PubMed ID: 32361317
[TBL] [Abstract] [Full Text] [Related]
9. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
[TBL] [Abstract] [Full Text] [Related]
10. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
[TBL] [Abstract] [Full Text] [Related]
11. The role of Ki-67 in Asian triple negative breast cancers: a novel combinatory panel approach.
Tan AS; Yeong JPS; Lai CPT; Ong CHC; Lee B; Lim JCT; Thike AA; Iqbal J; Dent RA; Lim EH; Tan PH
Virchows Arch; 2019 Dec; 475(6):709-725. PubMed ID: 31407032
[TBL] [Abstract] [Full Text] [Related]
12. Reclassification of breast cancer: Towards improved diagnosis and outcome.
Landry AP; Zador Z; Haq R; Cusimano MD
PLoS One; 2019; 14(5):e0217036. PubMed ID: 31116801
[TBL] [Abstract] [Full Text] [Related]
13. [Intravascular lymphoma simulating relapse of breast cancer: An original clinical case].
Herrscher H; Blind A; Freysz M; Cribier B; Mahé A
Ann Dermatol Venereol; 2019 Apr; 146(4):292-296. PubMed ID: 30904278
[TBL] [Abstract] [Full Text] [Related]
14. Anti-angiogenic efficacy in invasive breast carcinoma patients depends on clinicopathological determinants.
Zarychta E; Rhone P; Bielawski K; Michalska M; Rość D; Ruszkowska-Ciastek B
Adv Med Sci; 2019 Sep; 64(2):216-223. PubMed ID: 30818220
[TBL] [Abstract] [Full Text] [Related]
15. [Clinicopathologic features of breast lymphoma in core needle biopsy].
Rao J; Ruan M; Yu BH; Li XQ; Yang WT; Shui RH
Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):737-742. PubMed ID: 30317726
[No Abstract] [Full Text] [Related]
16. Analytical and clinical performance of progesterone receptor antibodies in breast cancer.
Calhoun BC; Mosteller B; Warren D; Smith M; Jordi Rowe J; Lanigan CP; Mrazeck KC; Walker E; Newell AH; Jones R
Ann Diagn Pathol; 2018 Aug; 35():21-26. PubMed ID: 29758480
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical and Pathologic Features of Myeloid Sarcoma].
Jiang YJ; Wang HX; Zhuang WC; Chen H; Zhang C; Li XM; Zhu GH; He Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):926-931. PubMed ID: 28641661
[TBL] [Abstract] [Full Text] [Related]
18. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
[TBL] [Abstract] [Full Text] [Related]
19. Increased number of endothelial progenitors in peripheral blood as a possible early marker of tumour growth in post-menopausal breast cancer patients.
Rhone P; Ruszkowska-Ciastek B; Celmer M; Brkic A; Bielawski K; Boinska J; Zarychta E; Rosc D
J Physiol Pharmacol; 2017 Feb; 68(1):139-148. PubMed ID: 28456778
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A
Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903
[TBL] [Abstract] [Full Text] [Related]
[Next]
